Open AccessCrystalloid (Ringer s Solution) Versus Colloid ...
Author(s) -
Funda Söğüt,
Türkan Kudsioğlu,
Nihan Yapıcı,
Hüseyin Maçika,
Zuhal Aykaç
Publication year - 2015
Publication title -
haseki tıp bülteni
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.113
H-Index - 4
eISSN - 2147-2688
pISSN - 1302-0072
DOI - 10.4274/haseki.2237
Subject(s) - ringer's solution , colloid , isotonic solutions , medicine , anesthesia , chemical engineering , engineering , isotonic
Aim: Various crystalloid and colloidal solutions are used to prime\udthe cardiopulmonary bypass (CPB) system. The aim of our study\udwas to compare the effects of crystalloids and colloids used as\udpriming solution during CPB.\udMethods: After the hospital scientific committee approval,\udinformed consent was obtained from 40 patients undergoing\udelective coronary artery bypass grafting (CABG). The patients were\udprospectively randomized to group 1 (n=20) receiving crystalloid\udas priming volume and to group 2 (n=20) receiving colloid (20 ml/\udkg) 6% HES 130/0.4. Anaesthesia and CPB were standardized.\udHaemodynamic measurements were recorded. Laboratory\udparameters and plasma colloid osmotic pressures were measured.\udResults: Cardiac index was higher in colloid group than in\udcrystalloid group after CPB. Plasma colloid osmotic pressure levels\udwere lower in crystalloid group than in colloid group. Postoperative\udbleeding and renal function were similar in both groups.\udConclusion: Crystalloids can be used as prime solution for\udeffective haemodilution but they lack oncotic activity. In this study,\udwe concluded that HES 130/0.4 has clinical efficiency and safety as\uda priming solution for CPB in adult patients. (The Medical Bulletin\udof Haseki 2015; 53:157-61